BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37918656)

  • 1. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
    Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
    Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
    Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
    JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Logistic Regression Classification of Primary Vitreoretinal Lymphoma versus Uveitis by Interleukin 6 and Interleukin 10 Levels.
    Kuo DE; Wei MM; Knickelbein JE; Armbrust KR; Yeung IYL; Lee AY; Chan CC; Sen HN
    Ophthalmology; 2020 Jul; 127(7):956-962. PubMed ID: 32197914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial changes in the aqueous IL-10 level after intravitreal methotrexate injection as an indicator of primary vitreoretinal lymphoma recurrence.
    Park YG; Park WK; Kim RY; Kim M; Park YH
    Sci Rep; 2020 Oct; 10(1):15992. PubMed ID: 33009434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
    Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
    Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Vitreoretinal Lymphoma -- A Review.
    Araujo I; Coupland SE
    Asia Pac J Ophthalmol (Phila); 2017; 6(3):283-289. PubMed ID: 28558176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
    Cheng CL; Yeh PT; Fang WQ; Ma WL; Hou HA; Tsai CH; Lin CP; Tien HF
    Cancer Med; 2023 Apr; 12(7):8102-8111. PubMed ID: 36602288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium.
    Chan CC; Rubenstein JL; Coupland SE; Davis JL; Harbour JW; Johnston PB; Cassoux N; Touitou V; Smith JR; Batchelor TT; Pulido JS
    Oncologist; 2011; 16(11):1589-99. PubMed ID: 22045784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation, Diagnostic Testing and Initial Treatment of Vitreoretinal Lymphoma.
    International Vitreoretinal B-Cell Lymphoma Registry Investigator Group
    Ophthalmol Retina; 2024 Jan; 8(1):72-80. PubMed ID: 37648063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
    Zhou N; Xu X; Liu Y; Wang Y; Wei W
    Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostics and treatment of primary vitreoretinal lymphoma].
    Stübiger N; Kakkassery V; Gundlach E; Winterhalter S; Pleyer U
    Ophthalmologe; 2015 Mar; 112(3):223-30. PubMed ID: 25698590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary vitreoretinal lymphoma: a diagnostic and management challenge.
    Soussain C; Malaise D; Cassoux N
    Blood; 2021 Oct; 138(17):1519-1534. PubMed ID: 34036310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
    Ahmed AH; Foster CS; Shields CL
    JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.
    Klimova A; Heissigerova J; Rihova E; Brichova M; Pytlik R; Spicka I; Mrazova K; Karolova J; Svozilkova P
    Br J Ophthalmol; 2018 Nov; 102(11):1579-1585. PubMed ID: 29378728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.
    Barry RJ; Tasiopoulou A; Murray PI; Patel PJ; Sagoo MS; Denniston AK; Keane PA
    Br J Ophthalmol; 2018 Oct; 102(10):1362-1366. PubMed ID: 29306864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
    Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
    Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Vitreoretinal Lymphoma Therapy Monitoring: Significant Vitreous Haze Reduction After Intravitreal Rituximab.
    Kakkassery V; Heindl LM; Rokohl AC; Chronopoulos A; Schutz JS; Ranjbar M; Schargus M; Böker A; Winterhalter S; Stübiger N
    Neurosignals; 2021 May; 29(S1):1-7. PubMed ID: 33945240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
    Hashida N; Nakai K; Saitoh N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.